the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010.
.
about
.
.
.
of all car-t cell trials registered since 2001, more than half are being conducted in china.
.
.
"the drug must be administered at the right time point during development," he said.
.
.
.